A1A79

7-[(3xi,5R)-5-C-(3,4-dichlorophenyl)-3-C-methyl-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Created:	2024-09-19
Last modified:	2025-02-12

Find Related PDB Entry
1 entries where A1A79 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	46
Chiral Atom Count	5
Bond Count	49
Aromatic Bond Count	16

2D diagram of A1A79

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	7-[(3xi,5R)-5-C-(3,4-dichlorophenyl)-3-C-methyl-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Systematic Name (OpenEye OEToolkits)	(2~{R},3~{S},4~{R},5~{R})-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)-2-[(~{R})-(3,4-dichlorophenyl)-oxidanyl-methyl]-3-methyl-oxolane-3,4-diol
Formula	C₁₈ H₁₈ Cl₂ N₄ O₄
Molecular Weight	425.266
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	Clc1ccc(cc1Cl)C(O)C1OC(n2ccc3c(N)ncnc32)C(O)C1(C)O
SMILES	CACTVS	3.385	C[C]1(O)[CH](O)[CH](O[CH]1[CH](O)c2ccc(Cl)c(Cl)c2)n3ccc4c(N)ncnc34
SMILES	OpenEye OEToolkits	2.0.7	CC1(C(C(OC1C(c2ccc(c(c2)Cl)Cl)O)n3ccc4c3ncnc4N)O)O
Canonical SMILES	CACTVS	3.385	C[C@]1(O)[C@@H](O)[C@@H](O[C@@H]1[C@H](O)c2ccc(Cl)c(Cl)c2)n3ccc4c(N)ncnc34
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@@]1([C@H]([C@@H](O[C@@H]1[C@@H](c2ccc(c(c2)Cl)Cl)O)n3ccc4c3ncnc4N)O)O
InChI	InChI	1.06	InChI=1S/C18H18Cl2N4O4/c1-18(27)13(26)17(24-5-4-9-15(21)22-7-23-16(9)24)28-14(18)12(25)8-2-3-10(19)11(20)6-8/h2-7,12-14,17,25-27H,1H3,(H2,21,22,23)/t12-,13+,14-,17-,18+/m1/s1
InChIKey	InChI	1.06	NVZVVFMXEHOMQR-FOOXYVKASA-N

Related Resource References

Resource Name	Reference
PubChem	137479770

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.